Latest Germany News

GreenX Metals has put a conceptual copper-silver target at Tannenberg and a major Poland arbitration award at the centre of its next phase. The annual report also shows the cost of that strategy: a $12.34 million loss, a $4.42 million project impairment and continued reliance on equity funding.

Nico Resources is advancing drilling, metallurgical studies and a potential downstream battery-materials partnership at Wingellina, despite a subdued nickel market and a larger annual loss. The company ended FY2026 with $4.73 million across cash and short-term investments after raising $3.73 million in equity.

Sonic Healthcare delivered a strong FY2026, with underlying net profit up 17% to A$621 million and dividends rising to A$1.08 per share. The next test is whether US efficiencies, LADR synergies and organic growth can offset Swiss fee cuts, a delayed UK contract ramp-up and heavier investment demands.

Bannerman Energy has moved its Etango uranium project materially closer to construction after completing a A$124 million placement and clearing conditions for its CNOL strategic investment. The project is advancing on site, but full-scale construction still depends on Final Investment Decision and completion of the joint venture documentation.

Rua Bioscience delivered a sharp rise in customer revenue and secured a UK agreement expected to generate NZ$10 million over two years. But PwC disclaimed an audit opinion, warning the company may not have enough cash without another capital raise.

EVT delivered growth across hotels, cinemas and Thredbo in FY2026 while outlining an approximately $500 million non-core property divestment programme. The group is also reviewing its structure as it redirects capital towards asset-light hotel expansion and considers potential special dividends.

Vulcan Energy has started commercial-scale production in Germany of VULSORB, the proprietary adsorbent at the centre of its planned direct lithium extraction process. The material will supply first-fill volumes for Project Lionheart, although lithium production remains targeted for the second half of 2028.

Atlas Arteria will pay securityholders an unfranked distribution of 20.0 Australian cents per stapled security for the six months to 30 June 2026. Securities go ex-entitlement on 23 September, with payment estimated for 7 October.

WAM Global’s portfolio earnings grew 18% in FY2026, but valuation compression and currency losses left the investment portfolio down about 4.2% in Australian-dollar terms. The listed investment company declared a 13.2 cents per share fully franked full-year dividend, backed by a stated 5.2 years of dividend coverage.

Vulcan Energy has secured a second lithium production licence for its Lionheart project in Germany, removing another regulatory milestone on the path to targeted production in 2028. The Ilka licence is initially valid for six years, leaving a future consolidation and extension process still to complete.

Way2VAT has secured binding commitments for a A$2.109 million placement, giving the fintech capital to fund the next RBC acquisition payment and its e-invoicing expansion. The raise comes at a 29% discount and carries potential further dilution through free-attaching options.

Impact Minerals (ASX: IPT) has pushed back the deadline for its $4.13 million renounceable rights issue by two days, offering shareholders more time to subscribe and clarifying the value of free attaching options.